A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: preliminary results of cancer and leukemia group B Trial 9780 (Q73287857)
Jump to navigation
Jump to search
scientific article published on 01 October 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: preliminary results of cancer and leukemia group B Trial 9780 |
scientific article published on 01 October 1999 |
Statements
A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: preliminary results of cancer and leukemia group B Trial 9780 (English)
D Savarese
M E Taplin
S Halabi
V Hars
W Kreis